FASEB SRC announces conference registration open for: Hematologic Malignancies

The Federation of American Societies for Experimental Biology (FASEB) announces the opening of registration for the Science Research Conference (SRC): Hematologic Malignancies.

The 2013 FASEB conference on Hematologic Malignancies is an important and unique scientific conference where basic and translational research on leukemias, lymphomas, and myeloma is presented in detail in the premier meeting in the field. The underlying theme for the 2013 conference is "Genomics and Targeted Therapy". This meeting includes outstanding researchers from around the world presenting cutting edge research directed towards genomic profiling of hematologic malignancies, mechanistic studies into hematopoietic transformation, and the development of novel, molecularly targeted therapies for patients with hematologic neoplasms.

FASEB SRC has announced a total of 34 SRCs in 2013. To register for an SRC, view preliminary programs, or find a listing of all our 2013 SRCs, please visit www.faseb.org/SRC.

Provided by Federation of American Societies for Experimental Biology